BIOLOGIC AGENTS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
Open Access
- 1 February 1996
- journal article
- review article
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 22 (1) , 117-132
- https://doi.org/10.1016/s0889-857x(05)70265-9
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritisArthritis & Rheumatism, 1995
- Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1Arthritis & Rheumatism, 1994
- Use of a chimeric monoclonal anti‐CD4 antibody in patients with refractory rheumatoid arthritisArthritis & Rheumatism, 1993
- The adhesion molecules of inflammationArthritis & Rheumatism, 1993
- The importance of the t cell in initiating and maintaining the chronic synovitis of rheumatoid arthritisArthritis & Rheumatism, 1992
- Evidence for the Effects of a Superantigen in Rheumatoid ArthritisScience, 1991
- Treatment of rheumatoid arthritis with monoclonal CD4 antibody M‐T151. Clinical results and immunopharmacologic effects in an open study, including repeated administrationArthritis & Rheumatism, 1991
- Treatment of rheumatoid arthritis with an anti‐CD4 monoclonal antibodyArthritis & Rheumatism, 1991
- The molecular basis of susceptibility to rheumatoid arthritis: The conformational equivalence hypothesisSpringer Seminars in Immunopathology, 1988
- Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II.Journal of Clinical Investigation, 1984